BrianDanielSchlickMD
Internal Medicine • Tullahoma, TNHematology/Oncology
Hematologist/Oncologist at Tennessee Oncology
Dr. Schlick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1750 Cedar LN Ste 200
Tullahoma, TN 37388Phone+1 931-393-3143
Summary
- Dr. Brian Schlick is an Internal Medicine specialist with subspecialties in Hematology and Oncology, based in Tullahoma, TN. He completed his Fellowship in Hematology and Medical Oncology at the University of South Florida Morsani in 2023, after finishing his Residency in Internal Medicine at Vanderbilt University Medical Center. Dr. Schlick graduated from the University of Chicago Division of the Biological Sciences The Pritzker School of Medicine in 2017. He is currently employed as a Hematologist/Oncologist at Tennessee Oncology since 2023. His research work includes publications on immune checkpoint inhibitors, cancer detection, and anti-PD-1-induced pneumonitis, which have collectively been cited 37 times. He received the Young Investigator Award from ASCO in 2022.
Education & Training
University of South Florida Morsani College of Medicine/Moffitt Cancer Center/Tampa General HospitalFellowship, Hematology and Medical Oncology, 2020 - 2023
Vanderbilt University Medical CenterResidency, Internal Medicine, 2017 - 2020
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2017
Certifications & Licensure
TN State Medical License 2019 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Young Investigator Award ASCO, 2022
Publications & Presentations
PubMed
- 10 citationsImmune Checkpoint Inhibitors and Chemoradiation for Limited-Stage Small Cell Lung Cancer.Brian Schlick, Misty Dawn Shields, Julian A Marin-Acevedo, Ishika Patel, Bruna Pellini
Current Treatment Options in Oncology. 2022-08-01 - 8 citationsCancer Detection and Classification by CpG Island Hypermethylation Signatures in Plasma Cell-Free DNA.Jinyong Huang, Alex C. Soupir, Brian D. Schlick, Mingxiang Teng, Ibrahim H. Sahin
Cancers. 2021-11-09 - 18 citationsAnti-PD-1-induced pneumonitis is associated with persistent imaging abnormalities in melanoma patientsDouglas B. Johnson, Kevin B. Taylor, Justine V. Cohen, Noura Ayoubi, Alexandra M Haugh
Cancer Immunology Research. 2019-08-28
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
